NASDAQ
Clearside Biomedical, Inc. (CLSD) has a fcf yield of -36.62% as of Friday, May 29, 2026. This represents a 126.28% decrease compared to its 12-month average of -16.18%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.